Abstract
In 1882, Friedrich von Recklinghausen described a clinical syndrome characterized primarily by tumors arising from nerves, called neurofibromas (Crump, 1981; Warkany, 1981). This report is generally recognized as the most thorough paper describing what is now termed von Recklinghausen neurofibromatosis, or neurofibromatosis type one (NF1). However, a number of previous reports in the medical and other literature as well as ancient artworks are also suggestive of NF1, indicating that this disease has likely been present throughout history (Riccardi and Eichner, 1986). NF1 obtained its misleading nickname of “The Elephant Man Disease” from Sir Frederick Treves’ depiction of Joseph Merrick, an Englishman afflicted with a disfiguring disease with features similar to NF1 (Treves, 1923; Rubenstein et al.,Nucleic Acids Res., 1981; Mulvihill, 1990a). NF1 gained much publicity and notoriety because of Merrick, as a widely performed play was written about his life and both the play and the movie based on it remain popular. However, it is now generally accepted that Merrick probably instead had Proteus syndrome, and the association of NF1 with the Elephant Man is being discouraged (Cohen, 1988), although Merrick’s diagnosis cannot be made with certainty (Hotamisligil, 1989).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Abuelo, D. N., and Meryash, D. L., 1988, Neurofibromatosis with fully expressed Noonan syndrome, Am. J. Med. Genet. 29: 937–941.
Andersen, L. B., Tommerup, N., and Koch, J., 1990, Formation of a minichromosome by excision of the proximal region of 17q in a patient with von Recklinghausen neurofibromatosis, Cytogenet. Cell Genet. 53: 206–210.
Andersen, L. B., Wallace, M. R., Marchuk, D. A., Cawthon, R. M., Odeh, H. M., Letcher, R., White, R. L., and Collins, F. S., 1991a, A polymorphic cDNA probe on chromosome 17qll.2 located within the von Recklinghausen neurofibromatosis gene [D17S376], Nucleic Acids Res. 19: 197.
Andersen, L. B., Wallace, M. R., Marchuk, D. A., Tavakkol, R., Mitchell, A., Saulino, A. M., and Collins, F. S., 1991, A highly polymorphic cDNA probe in the NF1 gene, Nucleic Acids Res., in press.
Bader, J. L., 1986, Neurofibromatosis and cancer, Ann. N. Y. Acad. Sci. 486: 57–65.
Ballester, R., Marchuk, D., Boguski, M., Saulino, A., Letcher, R., Wigler, M., and Collins, F. S., 1990, The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins, Cell 63: 851–859.
Barker, D., Wright, E., Nguyen, K., Cannon, L., Fain, P., Goldgar, D., Bishop, D. T., Carey, J., Kivlin, J., Willard, H., Nakamura, Y., O’Connell, P., Leppert, M., White, R., and Skolnick, M., 1987a, A genomic search for linkage of neurofibromatosis to RFLPs, J. Med. Genet. 24: 536–538.
Barker, D., Wright, E., Nguyen, K., Cannon, L., Fain, P., Goldgar, D., Bishop, D. T., Carey, J., Baty, B., Kivlin, J., Willard, H., Waye, J. S., Greig, G., Leinwand, L., Nakamura, Y., O’Connell, P., Leppert, M., Lalouel, J.-M., White, R., and Skolnick, M., 1987, Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17, Science 236: 1100–1102.
Berry, S. A., King, R. A., Whitley, C. B., Riccardi, V. M., and Peirpont, M. E. M., 1984, Familial neurofibromatosis resulting from a probable germinal mutation, Am. J. Hum. Genet. 36: 44s.
Bird, A. P., 1986, CpG-rich islands and the function of DNA methylation, Nature 321: 209–213.
Bolande, R. P., 1981, Neurofibromatosis — The quintessential neurocristopathy: Pathogenetic concepts and relationships, Adv. Neurol. 29: 67–75.
Borberg, A., 1951, Clinical and genetic investigations into tuberous sclerosis and Recklinghausen’s neurofibromatosis, Acta Psychiatr. Neurol. (Suppl.) 71: 1–239.
Borochowitz, Z., Berant, N., Dar, H., and Berant, M., 1989, The neurofibromatosis-Noonan syndrome: Genetic heterogeneity versus clinical variability, Neurofibromatosis 2: 309–314.
Brockes, J. P., Fields, K. L., and Raff, M. C., 1979, Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve, Brain Res. 165: 105–118.
Buchberg, A. M., Bedigian, H. G., Taylor, B. A., Brownell, E., Ihle, J. N., Nagata, S., Jenkins, N. A., and Copeland, N. G., 1988, Localization of evi-2 to chromosome 11: Linkage to other proto-oncogene and growth factor loci using interspecific backcross mice, Oncogene Res. 2: 149–165.
Buchberg, A. M., Brownell, E., Nagata, S., Jenkins, N. A., and Copeland, N. G., 1989, A comprehensive genetic map of murine chromosome 11 reveals extensive linkage conservation between mouse and human, Genetics 122: 153–161.
Buchberg, A. M., Cleveland, L. S., Jenkins, N. A., and Copeland, N. G., 1990, Sequence homology shared by neurofibromatosis type 1 gene and IRA1 and IRA2 negative
regulators of the RAS cyclic AMP pathway, Nature 347:291–294.
Burghes, A. H. M., Logan, C., Hu, B. B., Worton, R. G., and Ray, P. N., 1987, A cDNA clone from the Duchenne/Becker muscular dystrophy gene, Nature 328: 434–437.
Burmeister, M., Monaco, A. P., Gillard, E. F., van Ommen, G.-J., Affara, N. A., Ferguson-Smith, M. A., Kunkel, L. M., and Lehrach, H., 1988, A 10-megabase physical map of human Xp21, including the Duchenne muscular dystrophy gene, Genomics 2: 189–202.
Cardesa, A., Ribalta, T., Von Schilling, B., Palacin, A., and Mohr, U., 1989, Experimental model of tumors associated with neurofibromatosis, Cancer 63: 1737–1749.
Carey, J. C., Laub, J. M., and Hall, B. D., 1979, Penetrance and variability in neurofibromatosis: A genetic study of 60 families, Birth Defects: Orig. Artie. Ser. XV, (5B): 271–281.
Carle, G. F., Frank, M., and Olson, M. V., 1986, Electrophoretic separations of large DNA molecules by periodic inversion of the electric field, Science 232: 65–68.
Cartwright, S. C., 1982, Concordant optic glioma in a pair of monozygotic twins with neurofibromatosis, Clin. Pediatr. 21: 236–238.
Cawthon, R. M., Weiss, R., Xu, G., Viskochil, D., Culver, M., Stevens, J., Robertson, M., Dunn, D., Gesteland, R., O’Connell, P., and White, R., 1990a, A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations, Cell 62: 193–201.
Cawthon, R. M., O’Connell, P., Buchberg, A. M., Viskochil, D., Weiss, R. B., Culver, M., Stevens, J., Jenkins, N. A., Copeland, N. G., and White, R., 1990, Identification and characterization of transcripts from the neurofibromatosis 1 region: The sequence and genomic structure of EVI2 and mapping of other transcripts, Genomics 7: 555–565.
Cawthon, R. M., Andersen, L. B., Buchberg, A. M., Xu, G., O’Connell, P., Viskochil, D., Weiss, R. B., Wallace, M. R., Marchuk, D. A., Culver, M., Stevens, J., Jenkins, N. A., Copeland, N. G., Collins, F. S., and White, R., 1991, cDNA sequence and genomic structure of EVI2B, a gene lying within an intron of the neurofibromatosis type 1 gene, Genomics 9: 446–460.
Clark, R. D., and Hutter, J. J., 1982, Familial neurofibromatosis and juvenile chronic myeologenous leukemia, Hum. Genet. 60: 230–232.
Cohen, M. M., 1988, Further diagnostic thought about the elephant man, Am. J. Med. Genet. 29: 777–782.
Colley, A., Clayton-Smith, J., and Donnai, D., 1989, Noonan syndrome and neurofibromatosis type 1 segregating independently in a family, Am. J. Hum. Genet. 45: A43.
Collins, F. S., O’Connell, P., Ponder, B. A. J., and Seizinger, B. R., 1989a, Progress towards identifying the neurofibromatosis (NFJ) gene, Trends Genet. 5: 217–221.
Collins, F. S., Ponder, B. A., Seizinger, B. R., and Epstein, C. J., 19896, Editorial: The von Recklinghausen neurofibromatosis region on chromosome 17 —Genetic and physical maps come into focus, Am. J. Hum. Genet. 44: 1–5.
Cotton, R. G. H., Rodrigues, N. R., and Campbell, R. D., 1988, Reactivity of cytosine and thymine in single-base-pair mismatches with hydroxylamine and osmium tetroxide and its application to the study of mutations, Proc. Natl. Acad. Sci. USA 85: 4397–4401.
Crowe, F. W., Schull, W. T., and Neel, J. F., 1956, A Clinical, Pathological, and Genetic Study of Multiple Neurofibromatosis, Charles C. Thomas, Springfield, Illinois.
Crump, T., 1981, Translation of case reports in Ueber die multiplen Fibrone der Haut und ihre Beziehung zu den multiplen Neuromen by F. V. Recklinghausen, Adv. Neurol. 29: 259–275.
Darby, J. K., Feder, J., Selby, M., Riccardi, V., Ferrel, R., Siao, D., Goslin, K., Rutter, W., Shooter, E. M., and Cavalli-Sforza, L. L., 1985, A discordant sibship analysis between beta-NGF and neurofibromatosis, Am. J. Hum. Genet. 37: 52–59.
Davis, F. A., 1940, Primary tumors of the optic nerve (a phenomenon of Recklinghausen’s disease), Arch. Opthalmol. 23:735–821, 957–1022.
Diehl, S. R., Boehnke, M., Collins, F. S., Eriekson, R. P., Karolyi, I. J., Ploughman, L. M., Pericak-Vance, M. A., Aylsworth, A. S., and Roses, A. D., 1987a, Linkage analysis of peripheral neurofibromatosis to DNA markers on chromosome 8, J. Med. Genet. 24: 532–534.
Diehl, S. R., Boehnke, M., Eriekson, R. P., Baxter, A. B., Bruce, M. A., Lieberman, J. L., Piatt, D. J., Ploughman, L. M., Seiler, K. A., Sweet, A. M., and Collins, F. S., 19876, Linkage analysis of von Recklinghausen neurofibromatosis to DNA markers on chromosome 17, Genomics 1: 361–363.
Diehl, S. R., Boehnke, M., Eriekson, R. P., Ploughman, L. M., Seiler, K. A., Lieberman, J. L., Clarke, H. B., Bruce, M. A., Schorry, E. K., Pericak-Vance, M., O’Connell, P., and Collins, F. S., 1989, A refined genetic map of the region of chromosome 17 surrounding the von Recklinghausen neurofibromatosis (NF1) gene, Am. J. Hum. Genet. 44: 33–37.
Dietz, J. N., Robbins, T., Cannon, L. A., Schwartz, C. E., Carey, J. C., Johnson, J. P., Kivlin, J., and Skolnick, M. H., 1986, Linkage analysis of von Recklinghausen neurofibromatosis: Chromosomes 4 and 19, Genet. Epidemiol. 3: 313–321.
Duncan, A. M. V., Partington, M. W., and Soudek, D., 1987, Neurofibromatosis in a man with a ring 22: in situ hybridization studies, Cancer Genet. Cy to genet. 25: 169–174.
Dunn, B. G., Ferrell, R. E., and Riccardi, V. M., 1985, A genetic linkage study in 15 families of individuals with von Recklinghausen neurofibromatosis, Am. J. Med. Genet. 22: 403–407.
Eldridge, R., 1981, Central neurofibromatosis with bilateral acoustic neuroma, Adv. Neurol. 29: 57–65.
Fabricant, R. N., Todaro, G. J., and Eldridge, R., 1979, Increased levels of a nerve- growth-factor cross-reacting protein in “central” neurofibromatosis, Lancet 1: 4–1.
Fain, P. R., Barker, D. F., Goldgar, D. E., Wright, E., Nguyen, K., Carey, J., Johnson, J., Kivlin, J., Willard, H., Mathew, C., Ponder, B., and Skolnick, M., 1987, Genetic analysis of NF1: Identification of close flanking markers on chromosome 17, Genomics 1: 340–345.
Fain, P. R., Goldgar, D. E., Wallace, M. R., Collins, F. S., Wright, E., Nguyen, K., and Barker, D. F., 1989a, Refined physical and genetic mapping of the NF1 region on chromosome 17, Am. J. Hum. Genet. 45: 721–728.
Fain, P. R., Wright, E., Willard, H. F., Stephens, K., and Barker, D. F., 19896, The order of loci in the pericentric region of chromosome 17, based on evidence from physical and genetic breakpoints, Am. J. Hum. Genet. 44: 68–72.
Ferrell, R. E., Buetow, K. H., Darby, J. K., Eichner, J. E., Murray, J. C., Smith, R., Waziri, M., Huson, S., and Riccardi, V. M., 1987, Von Recklinghausen neurofibromatosis: A linkage study of candidate and random marker genes, J. Med. Genet. 24: 522–524.
Fialkow, P. J., Sagebiel, R. W., Gartler, S. M., and Rimoin, D. L., 1971, Multiple cell origin of hereditary neurofibromatosis, N. Engl. J. Med. 284: 298–300.
Fountain, J. W., 1989, Search for the gene involved in von Recklinghausen neurofibromatosis, Ph.D. thesis, University of Michigan.
Fountain, J. W., Wallace, M. R., Brereton, A. B., O’Connell, P., White, R. L., Rich, D. C., Ledbetter, D. H., Leach, R. J., Fournier, R. E. K., Menon, A. G., Gusella, J. F., Barker, D., Stephens, K., and Collins, F. S., 1989a, Physical mapping of the von Recklinghausen neurofibromatosis region on chromosome 17, Am. J. Hum. Genet. 44: 58–67.
Fountain, J. W., Wallace, M. R., Bruce, M. A., Seizinger, B. R., Menon, A. G., Gusella, J. F., Michels, V. V., Schmidt, M. A., Dewald, G. W., and Collins, F. S., 19896, Physical mapping of a translocation breakpoint in neurofibromatosis, Science 244: 1085–1087.
Frankel, J. W., Bidot, P., and Kopelovich, L., 1986, Enhanced sensitivity of skin fibroblasts from neurofibromatosis patients to transformation by the Kirsten murine sarcoma virus, Ann. N. Y. Acad. Sci. 486: 403–412.
Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., and Dryja, T. P., 1986, A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma, Nature 323: 643–646.
Glover, T. W., Stein, C. K., Legius, E., Andersen, L. B., Brereton, A., and Johnson, S., 1991, Molecular and cytogenetic analysis of tumors in von Recklinghausen neurofibromatosis, Genes Chromosomes Cancer 3: 62–70.
Goerg, C., Goerg, K., Pflueger, K.-H., and Havemann, K., 1989, Neurofibromatosis and acute monocytic leukemia in adults, Cancer 64: 1717–1719.
Goldgar, D. E., Green, P., Parry, D. M., and Mulvihill, J. J., 1989, Multipoint linkage analysis in neurofibromatosis type 1: An international collaboration, Am. J. Hum. Genet. 44: 6–12.
Gutmann, D. H., Wood, D. L., and Collins, F. S., 1991, Identification of the neurofibromatosis type 1 gene product, Proc. Natl. Acad. Sci. USA, in press.
Hafez, M., Sharaf, L., El-Nabi, S. M. A., and El-Wehedy, G., 1985, Evidence of chromosomal instability in neurofibromatosis, Cancer 55: 2434–2436.
Haines, J. L., Ozelius, L. J., McFarlane, H., Menon, A., Tzall, S., Martiniuk, F., Hirschhorn, R., and Gusella, J. F., 1990, A genetic linkage map of chromosome 17, Genomics 8: 1–6.
Hall, A., 1990, ras and GAP —Who’s controlling whom?, Cell 61: 921–923.
Hall, J. G., 1981, Possible maternal and hormonal factors in neurofibromatosis, Adv. Neurol. 29: 125–131.
Harper, P. S., 1987, Gene mapping and neurogenetics, J. Med. Genet. 24: 513–514.
Hinrichs, S. H., Nerenberg, M., Reynolds, R. K., Khoury, G., and Jay, G., 1987, A transgenic mouse model for human neurofibromatosis, Science 237: 1340–1343.
Hoffman, E. P., Kunkel, L. M., Angelini, C., Clarke, A., Johnson, M., and Harris, J. B., 1989, Improved diagnosis of Becker muscular dystrophy by dystrophin testing, Neurology 39: 1011–1017.
Hotamisligil, G. S., 1989, Proteus syndrome and neurofibromatosis, Neurofibromatosis 2: 339–340.
Huson, S. M., 1987, The first European symposium on neurofibromatosis, J. Med. Genet. 24: 572–573.
Huson, S. M., 1989, Recent developments in the diagnosis and management of neurofibromatosis. Arch. Dis. Child. 64: 745–749.
Huson, S. M., and Thrush, D. C., 1985, Central neurofibromatosis, Q. J. Med. 55: 213–224.
Huson, S. M., Meredith, A. L., Sarfarazi, M., Shaw, D. J., Brook, B., Compston, D. A. S., and Harper, P. S., 1986, Evidence against linkage of von Recklinghausen neurofibromatosis and chromosome 19 markers, Ann. N. Y. Acad. Sci. 486: 349–353.
Ichikawa, K., Crosley, C. J., Culebras, A., and Weitkamp, L., 1981, Coincidence of neurofibromatosis and myotonic dystrophy in a kindred, J. Med. Genet. 18: 134–138.
Jaakkola, S., Peltonen, J., Riccardi, V., Chu, M.-L., and Uitto, J., 1989, Type 1 neurofibromatosis: Selective expression of extracellular matrix genes by Schwann cells, perineu- rial cells, and fibroblasts in mixed cultures, J. Clin. Invest. 84: 253–261.
Jadayel, D., Fain, P., Upadhyaya, M., Ponder, M. A., Huson, S. M., Carey, J., Fryer, A., Mathew, C. G. P., Barker, D. F., and Ponder, B. A. J., 1990, Paternal origin of new mutations in von Recklinghausen neurofibromatosis, Nature 343: 558–559.
Kamata, Y., 1978, On the ultrastructure and acetylcholinesterase activity in von Recklinghausen neurofibromatosis, Acta Pathol. Jpn. 28: 393–410.
Kanter, W. R., Eldridge, R., Fabricant, R., Allen, J. C., and Koerber, T., 1980, Central neurofibromatosis with bilateral acoustic neuroma: Genetic, clinical, and biochemical distinctions from peripheral neurofibromatosis, Neurology 30:851–-859.
Kittur, S., Lubs, M. L., Bauer, M., Chakravarti, A., and Kazazian, H., 1987, Linkage analysis of neurofibromatosis, J. Med. Genet. 24: 526–527.
Kittur, S. D., Bagdon, M. M., Lubs, M. L., Phillips III, J. A., Murrary, J. C., Slaugenhaupt, S. A., Chakravarti, A., and Adler, W. H., 1989, Linkage analysis of neurofibromatosis type 1, using chromosome 17 DNA markers, Am. J. Hum. Genet. 44: 48–50.
Knudson, A. G., 1971, Mutation and cancer: Statistical study of retinoblastoma, Proc. Natl. Acad. Sci. USA 68: 820–823.
Knudson, A. G., 1985, Hereditary cancer, oncogenes, and antioncogenes, Cancer Res. 45: 1437–1443.
Kopelovich, L., and Rich, R. F., 1986, Enhanced radiotolerance to ionizing radiation is correlated with increased cancer proneness of cultured fibroblasts from precursor states in neurofibromatosis patients, Cancer Genet. Cytogenet. 22: 203–210.
Korf, B. R., and Carey, J. C., 1990, Molecular genetics of neurofibromatosis, in: Neurofibromatosis: A Handbook for Patients, Families, and Health-Care Professionals ( A. E. Rubenstein and B. R. Korf, eds.), Thieme Medical Publishers, New York, pp. 178–200.
Krone, W., and Hogemann, I., 1986, Cell culture studies on neurofibromatosis (von Recklinghausen) V. Monosomy 22 and other chromosomal anomalies in cultures from peripheral neurofibromas, Hum. Genet. 74: 453–455.
Krone, W., Jirikowski, G., Muhleck, O., Kling, H., and Gall, H., 1983, Cell culture studies on neurofibromatosis (von Recklinghausen). II. Occurrence of glial cells in primary cultures of peripheral neurofibromas, Hum. Genet. 63: 247–251.
Krone, W., Mao, R., Muhleck, S., Kling, H., and Fink, T., 1986, Cell culture studies on neurofibromatosis (von Recklinghausen): Characterization of cells growing from neurofibromas, Ann. N. Y. Acad. Sci. 486: 354–370.
Leach, R. J., Thayer, M. J., Schafer, A. J., and Fournier, R. E. K., 1989, Physical mapping of human chromosome 17 using fragment-containing microcell hybrids, Genomics 5: 167–176.
Ledbetter, D. H., Rich, D. C., O’Connell, P., Leppert, M., and Carey, J. C., 1989, Precise localization of NF1 to 17ql 1.2 by balanced translocation, Am. J. Hum. Genet. 44: 20–24.
Lefkowitz, I. B., Obringer, A. C., and Meadows, A. T., 1990, Neurofibromatosis and cancer: Incidence and management, in Neurofibromatosis: A Handbook for Patients, Families, and Health-Care Professionals ( A. E. Rubenstein and B. R. Korf, eds.), Thieme Medical Publishers, New York, pp. 99–111.
Lemke, G., 1990, Mitogen signal (letter), Nature 348: 201.
Lemke, G. E., and Brockes, J. P., 1983, Glial growth factor: A mitogenic polypeptide of the brain and pituitary, Fed. Proc. 42: 2627–2629.
Levinson, B., Kenwrick, S., Lakich, D., Hammonds, G., and Gitschier, J., 1990, A transcribed gene in an intron of the human factor VIII gene, Genomics 7: 1–11.
Lugo, T. G., Leach, R. J., and Fournier, R. E. K., 1986, Parasexual approaches to the study of human genetic disease, Ann. N. Y. Acad. Sci. 486: 293–303.
Marchuk, D. A., Saulino, A. M., Tavakkol, R. L., Swaroop, M., Wallace, M. R., Andersen, L. B., Mitchell, A. M., Gutmann, D. H., and Collins, F. S., 1991, The complete coding sequence of the type 1 neurofibromatosis cDNA, Genomics, in press.
Martin, G. A., Viskochil, D., Bollag, G., McCabe, P. C., Crosier, W. J., Haubruck, H., Conroy, L., Clark, R., O’Connell, P., Cawthon, R. M., Innis, M. A., and McCormick, F., 1990, The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21, Cell 63: 843–849.
Martuza, R. L., and Eldridge, R., 1988, Neurofibromatosis 2 (bilateral acoustic neurofibromatosis), N. Engl. J. Med. 318: 684–688.
Martuza, R. L., MacLaughlin, D. T., and Ojemann, R. G., 1981, Specific estradiol binding in schwannomas, meningiomas, and neurofibromas, Neurosurgery 9: 665–671.
Mathew, C. G. P., Thorpe, K., Easton, D. F., Carter, C., Wallis, C., Wong, Z., Jeffreys, A. J., and Ponder, B. A. J., 1987, Linkage analysis of British and Indian families with von Recklinghausen neurofibromatosis, J. Med. Genet. 24: 524–526.
Mathew, C. G. P., Thorpe, K., Easton, D. F., Chin, K. S., Jadayel, D., Ponder, M., Moore, Wallis, C. E., Slater, C. P., De Jong, G., O’Connell, P., White, R., Barker, D., and Ponder, B. A. J., 1989, Linkage analysis of chromosome 17 markers in British and South African families with neurofibromatosis type 1, Am. J. Hum. Genet. 44: 38–40.
Mayfrank, L., Wullich, B., Wolff, G., Finke, J., Gouzoulis, E., and Gilsbach, J. M., 1990, Neurofibromatosis 2: A clinically and genetically heterogeneous disease? Report on 10 sporadic cases, Clin. Genet. 38: 362–370.
Menon, A. G., Ledbetter, D. H., Rich, D. C., Seizinger, B. R., Rouleau, G. A., Michels, V. V., Schmidt, M. A., Dewald, G., DallaTorre, C. M., Haines, J. L., and Gusella, J. F., 1989, Characterization of a translocation within the von Recklinghausen neurofibromatosis region of chromosome 17, Genomics 5: 245–249.
Menon, A. G., Anderson, K. M., Riccardi, V. M., Chung, R. Y., Whaley, J. M., Yandell, D. W., Farmer, G. E., Freiman, R. N., Lee, J. K., Li, F. P., Barker, D. F., Ledbetter, D., Kleider, A., Martuza, R. L., Gusella, J. F., and Seizinger, B. R., 1990, Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis, Proc. Natl. Acad. Sci. USA 87: 5435–5439.
Mikol, D. D., Gulcher, J. R., and Stefansson, K., 1990, The oligodendrocyte-myelin glycoprotein belongs to a distinct family of proteins and contains the HNK-1 carbohydrate, Cell Biol. 110: 471–480.
Miller, M., and Hall, J. G., 1978, Possible maternal effect on severity of neurofibromatosis, Lancet 2: 1071–1074.
Monaco, A. P., Neve, R. L., Colletti-Feener, C., Bertelson, C. J., Kurnit, D. M., and Kunkel, L. M., 1986, Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene, Nature 323: 646–650.
Mulvihill, J. J., 1990a, Introduction and history, in: Neurofibromatosis: A Handbook for Patients, Families, and Health-Care Professionals ( A. E. Rubenstein and B. R. Korf, eds.), Thieme Medical Publishers, New York, pp. 1–15.
Mulvihill, J. J. (moderator), \990b, Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis): An update, Ann. Intern. Med. 113: 39–52.
Mulvihill, J. J., and Parry, D. M., 1987, Symposium on linkage of von Recklinghausen neurofibromatosis (NF1), Genomics 1: 337–339.
Nakamura, T., Hara, M., and Kasuga, T., 1989, Transplacental induction of peripheral nervous tumor in the Syrian golden hamster by TV-nitroso-TV-ethylurea, Am. J. Pathol. 135: 251–259.
Nakamura, Y., Lathrop, M., O’Connell, P., Leppert, M., Barker, D., Wright, E., Skolnick, M., Kondoleon, S., Litt, M., Lalouel, J.-M., and White, R., 1988, A mapped set of DNA markers for human chromosome 17, Genomics 2: 302–309.
Nigro, J. M., Baker, S. J., Presinger, A. C., Jessup, J. M., Hostetter, R., Cleary, K., Bigner, S. H., Davidson, N., Baylin, S., Devilee, P., Glover, T., Collins, F. S., Weston, A., Modali, R., Harris, C. C., and Vogelstein, B., 1989, Mutations in thep53 gene occur in diverse human tumour types, Nature 342: 705–708.
Nozue, A. T., and Ono, S., 1989, Exposure of newborn mice to adenosine causes neural crest dysplasia and tumor formation, Neurofibromatosis 2: 261–273.
O’Connell, P., Leach, R. J., Ledbetter, D. H., Cawthon, R. M., Culver, M., Eldridge, J. R., Frej, A.-K., Holm, T. R., Wolff, E., Thayer, M. J., Schafer, A. J., Fountain, J. W., Wallace, M. R., Collins, F. S., Skolnick, M. H., Rich, D. C., Fournier, R. E. K., Baty, B. J., Carey, J. C., Leppert, M. F., Lathrop, G. M., Lalouel, J.-M., and White, R., 1989a, Fine structure DNA mapping studies of the chromosomal region harboring the genetic defect in neurofibromatosis type 1, Am. J. Hum. Genet. 44: 51–57.
O’Connell, P., Leach, R., Cawthon, R. M., Culver, M., Stevens, J., Viskochil, D., Fournier, R. E. K., Rich, D. C., Ledbetter, D. H., and White, R., 1989b, Two NF1 translocations map within a 600-kilobase segment of 17qll.2, Science 244: 1087–1088.
O’Connell, P., Viskochil, D., Buchberg, A. M., Fountain, J., Cawthon, R. M., Culver, M., Stevens, J., Rich, D. C., Ledbetter, D. H., Wallace, M., Carey, J. C., Jenkins, N. A., Copeland, N. G., Collins, F. S., and White, R., 1990, The human homolog of murine evi2 lies between two von Recklinghausen neurofibromatosis translocations, Genomics 7: 547–554.
Opitz, J. M., and Weaver, D. D., 1985, The neurofibromatosis-Noonan syndrome, Am. J. Med. Genet. 21: 477–490.
Oranje, A. P., Vuzerski, V. D., Kalis, T. J., Arts, W. F. M., Van Joost, T., and Stolz, E., 1985, Segmental neurofibromatosis, Br. J. Dermatol. 112: 107–112.
Orita, M., Suzuki, Y., Sekiya, T., and Hayashi, K., 1989, Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction, Genomics 5: 874–879.
Peltonen, J., Aho, H., Rinne, U. K., and Penttinen, R., 1983, Neurofibromatosis tumor and skin cells in culture, Acta Neuropathol. 61: 275–282.
Peltonen, J., Jaakkola, S., Lebwohl, M., Renvall, S., Risteli, L., Virtanen, I., and Uitto, J., 1988, Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis, Lab. Invest. 59: 760–771.
Penrose, L. S., 1957, Parental age in achondroplasia and mongolism, Am. J. Hum. Genet. 9: 167–169.
Pericak-Vance, M. A., Yamaoka, L. H., Vance, J. M., Aylsworth, A. S., Rossenwasser, G. O. D., Gaskell, P. C., Alberts, M. J., Hung, W.-Y., Haynes, C., and Roses, A. D., 1987a, Linkage studies in peripheral neurofibromatosis, J. Med. Genet. 24: 530–532.
Pericak-Vance, M. A., Yamaoka, L. H., Vance, J. M., Small, K., Rosenwasser, G. O. D., Gaskell, P. C., Hung, W.-Y., Alberts, M. J., Haynes, C. S., Speer, M. C., Gilbert, J. R., Herbstreith, M., Aylsworth, A. S., and Roses, A. D., 1987£, Genetic linkage studies of chromosome 17 RFLPs in von Recklinghausen neurofibromatosis (NF1), Genomics 1: 349–352.
Perry, H. D., and Font, R. L., 1982, Iris nodules in von Recklinghausen’s neurofibromatosis, Arch. Ophthalmol. 100: 1635–1640.
Pintar, J. E., Sonnenfeld, K. H., Fisher, J., Klein, R. S., and Kreider, B., 1986, Molecular and immunocytochemical studies of neurofibromas and related cell types, Ann. N. Y. Acad. Sci. 486: 96–106.
Pleasure, D., Kreider, B., Shuman, S., and Sobue, G., 1985, Tissue culture studies of Schwann cell proliferation and differentiation, Dev. Neurosci. 7: 364–373.
Pleasure, D., Kreider, B., Sobue, G., Ross, A. H., Koprowski, H., Sonnenfeld, K. H., and Rubenstein, A. E., 1986, Schwann-like cells cultured from human dermal neurofibromas: Immunohistological identification and response to Schwann cell mitogens, Ann. N. Y. Acad. Sci. 486: 227–240.
Ratner, N., Lieberman, M. A., Riccardi, V. M., and Hong, D., 1990, Mitogen accumulation in von Recklinghausen neurofibromatosis, Ann. Neurol. 27: 298–303.
Rawlings, C. E., III, Wilkins, R. H., Cook, W. A., and Burger, P. C., 1987, Segmental neurofibromatosis, Neurosurgery 20: 946–949.
Rey, J. A., Bello, M. J., de Campos, J. M., Benitez, J., Sarasa, J. L., Boixados, J. R., and Sanchez Cascos, A., 1987, Cytogenetic clones in a recurrent neurofibroma, Cancer Genet. Cytogenet. 26: 157–163.
Riccardi, V. M., 1981, Von Recklinghausen neurofibromatosis, N. Engl. J. Med. 305: 1617–1627.
Riccardi, V. M., 1986, Growth-promoting factors in neurofibroma crude extracts, Ann. N. Y. Acad. Sci. 486: 66–86.
Riccardi, V. M., 1989a, Neurofibromatosis update, Neurofibromatosis 2: 284–291.
Riccardi, V. M., 1989b> Syndromology gone awry—The phenotypic overlap of NF1 with the Noonan syndrome, Neurofibromatosis 2: 249–250.
Riccardi, V. M., 1989c, Genetic alterations and growth factors in the pathogenesis of von Recklinghausen neurofibromatosis, Neurofibromatosis 2: 292–298.
Riccardi, V. M., and Eichner, J. E., 1986, Neurofibromatosis: Phenotype, Natural History, and Pathogenesis, Johns Hopkins University Press, Baltimore, Maryland.
Riccardi, V. M., and Elder, D. W., 1986, Multiple cytogenetic aberrations in neurofibrosarcomas complicating neurofibromatosis, Cancer Genet. Cytogenet. 23: 199–209.
Riccardi, V. M., and Lewis, R. A., 1988, Penetrance of von Recklinghausen neurofibromatosis: A distinction between predecessors and descendents, Am. J. Hum. Genet. 42: 284–289.
Riccardi, V. M., and Mulvihill, J. J. (eds.), 1981, Adv. Neurol. 29: 1–277.
Riccardi, S. L., and Riccardi, V. M., 1981, Neurofibromatosis: Lack of an adverse maternal affect on overall severity in offspring, Am. J. Hum. Genet. 33: 89A.
Riccardi, V. M., and Wald, J. S., 1987, Discounting an adverse maternal effect on severity of neurofibromatosis, Pediatrics 79: 386–393.
Riccardi, V. M., Dobson, C. E., Chakraborty, R., and Bontke, C., 1984, The pathophysiology of neurofibromatosis: ix. Paternal age as a factor in the origin of new mutations, Am. J. Med. Genet. 18: 169–176.
Riopelle, R. J., Riccardi, V. M., Faulkner, S., and Martin, M. C., 1984, Serum neuronal growth factors in von Recklinghausen neurofibromatosis, Ann. Neurol. 16: 54–59.
Rivas, M. L., and DiLiberti, J. H., 1984, Genetic linkage between myotonic dystrophy and neurofibromatosis, Cytogenet. Cell Genet. 37: 570–571.
Ross, A. H., Pleasure, D., Sonnenfeld, K., Atkinson, B., Kreider, B., Jackson, D. M., Taff, I., Scarpini, E., Lisak, R. P., and Koprowski, H., 1986, Expression of melanoma- associated antigens by normal and neurofibroma Schwann cells, Cancer Res. 46: 5887–5892.
Roth, R. R., Martines, R., and James, W. D., 1987, Segmental neurofibromatosis, Arch. Dermatol. 123: 917–920.
Rouleau, G. A., Wertelecki, W., Haines, J. L., Hobbs, W. J., Trofatter, J. A., Seizinger, B. R., Martuza, R. L., Superneau, D. W., Conneally, P. M., and Gusella, J. F., 1987, Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22, Nature 329: 246–248.
Rouleau, G. A., Seizinger, B. R., Wertelecki, W., Haines, J. L., Superneau, D. W., Martuza, R. L., and Gusella, J. F., 1990, Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22, Am. J. Hum. Genet. 46: 323–328.
Rubenstein, A. E., and Korf, B. R. (ed.), 1990, Neurofibromatosis: A Handbook for Patients, Families, and Health-Care Professionals. Thieme Medical Publishers, New York. Rubenstein, A. E., Bunge, R., and Housman, D., (eds.), 1986, Ann. N. Y. Acad. Sci. 486: 1–414.
Rubenstein, A. E., Mytilineou, C., Yahr, M. D., and Revoltella, R. P., 1981, Neurological aspects of neurofibromatosis, Adv. Neurol. 29: 11–20.
Sager, R., 1989, Tumor suppressor genes: The puzzle and the promise, Science 246: 1406–1412.
Samuelsson, B., and Axelsson, R., 1981, Neurofibromatosis, Acta Dermatovenerol. (Suppl.) 95: 67–91.
Sarfarazi, M., Huson, S. M., and Edwards, J. H., 1987, An exclusion map for von Recklinghausen neurofibromatosis, J. Med. Genet. 24: 515–520.
Schmale, M. C., and Hensley, G. T., 1988, Transmissibility of a neurofibromatosis-like disease in bicolar damselfish, Cancer Res. 48: 3828–3833.
Schmale, M. C., Hensley, G., and Udey, L. R., 1983, Neurofibromatosis, von Recklinghausen’s disease, multiple Schwannomas, malignant Schwannomas, Am. J. Pathol. 112: 238–241.
Schmale, M. C., Hensley, G. T., and Udey, L. R., 1986, Neurofibromatosis in the bicolor damselfish as a model of von Recklinghausen neurofibromatosis, Ann. N. Y. Acad. Sci. 486: 386–402.
Schmidt, M. A., Michels, V. V., and Dewald, G. W., 1987, Cases of neurofibromatosis with rearrangements of chromosome 17 involving band 17qll.2, Am. J. Med. Genet. 28: 771–777.
Seizinger, B. R., Martuza, R. L., and Gusella, J. F., 1986a, Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma, Nature 322: 664–667.
Seizinger, B. R., Tanzi, R. E., Gilliam, T. C., Bader, J. L., Parry, D. M., Spence, M. A., Marazita, M. L., Gibbons, K., Hobbs, W., and Gusella, J. F., 1986b, Genetic linkage analysis of neurofibromatosis with DNA markers, Ann. N. Y. Acad. Sci. 486: 304–310.
Seizinger, B. R., Rouleau, G., Ozelius, L. J., Lane, A. H., St. George-Hyslop, P., Huson, S., Gusella, J. F., and Martuza, R. L., 1987a, Common pathogenetic mechanism for three tumor types in bilateral acoustic neurofibromatosis, Science 236: 317–319.
Seizinger, B. R., Rouleau, G. A., Ozelius, L. J., Lane, A. H., Faryniarz, A. G., Chao, M. V., Huson, S., Korf, B. R., Parry, D. M., Pericak-Vance, M. A., Collins, F. S., Hobbs, W. J., Falcone, B. G., Iannazzi, J. A., Roy, J. C., St. George-Hyslop, P. H., Tanzi, R. E., Both well, M. A., Upadhyaya, M., Harper, P., Goldstein, A. E., Hoover, D. L., Bader, J. L., Spence, M. A., Mulvihill, J. J., Aylsworth, A. S., Vance, J. M., Rossenwasser, G. O. D., Gaskell, P. C., Roses, A. D., Martuza, R. L., Breakefield, X. O., and Gusella, J. F., 1987, Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene, Cell 49: 589–594.
Seizinger, B. R., Rouleau, G., Lane, A. H., Ozelius, L. J., Faryniarz, A. G., Iannazzi, J., Hobbs, W., Roy, J. C., Falcone, B., Huson, S., Harper, P. S., Parry, D. M., Bader, J. L., Spence, M. A., and Gusella, J. F., 1987c, DNA linkage analysis in von Recklinghausen neurofibromatosis, J. Med. Genet. 24: 529–530.
Seizinger, B. R., Farmer, G. E., Haines, J. L., Ozelius, L. J., Anderson, K., Korf, B. R., Parry, D. M., Pericak-Vance, M. A., Mulvihill, J. J., Menon, A., Hobbs, W. J., Martuza, R. L., and Gusella, J. F., 1989, Flanking markers for the gene causing von Recklinghausen neurofibromatosis (NF1), Am. J. Hum. Genet. 44: 30–32.
Sergeyev, A. S., 1975, On the mutation rate of neurofibromatosis, Hum. Genet. 28: 129–138.
Sheela, S., Riccardi, V. M., and Ratner, N., 1990, Angiogenic and invasive properties of neurofibroma Schwann cells, J. Cell Biol. 111: 645–653.
Shew, J.-Y., Ling, N., Yang, X., Fodstad, O., and Lee, W.-H., 1989, Antibodies detecting abnormalities of the retinoblastoma susceptibility gene product (ppllORB) in osteosarcomas and synovial sarcomas, Oncogene Res. 1: 205–214.
Skolnick, M. H., Ponder, B., and Seizinger, B., 1987, Linkage of NF1 to 12 chromosome 17 markers: A summary of eight concurrent reports, Genomics 1: 382–383.
Skuse, G. R., Kosciolek, B. A., and Rowley, P. T., 1989, Molecular genetic analysis of tumors in von Recklinghausen neurofibromatosis: Loss of heterozygosity for chromosome 17, Genes Chromosomes Cancer 1: 36–41.
Sobue, G., Sonnenfeld, K., Rubenstein, A. E., and Pleasure, D., 1985, Tissue culture studies of neurofibromatosis: Effects of axolemmal fragments and cyclic adenosine 3′,5′- monophosphate analogues on proliferation of Schwann-like and fibroblast-like neurofibroma cells, Ann. Neurol. 18: 68–73.
Sonnenfeld, K. H., Bernd, P., Sobue, G., Lebwohl, M., and Rubenstein, A. E., 1986, Nerve growth factor receptors on dissociated neurofibroma Schwann cells, Cancer Res. 46: 1446–1452.
Sørensen, S. A., Mulvihill, J. J., and Neilsen, A., 1986, Long-term follow-up on von Recklinghausen neurofibromatosis, N. Engl. J. Med. 314: 1010–1015.
Spence, M. A., Bader, J. L., Parry, D. M., Field, L. L., Funderburk, S. J., Rubenstein, A. E., Gilman, P. A., and Sparkes, R. S., 1983, Linkage analysis of neurofibromatosis (von Recklinghausen disease), J. Med. Genet. 20: 334–337.
Spence, M. A., Parry, D. M., Bader, J. L., Marazita, M. L., Bocian, M., Funderburk, S. J., Julvihill, J. J., and Sparkes, R. S., 1986, Genetic linkage analysis of neurofibromatosis, Ann. N. Y. Acad. Sci. 486: 287–292.
Stephens, K., Riccardi, V. M., Rising, M., Ng, S., Green, P., Collins, F. S., Rediker, K. S., Powers, J. A., Parker, C., and Donis-Keller, H., 1987, Linkage studies with chromosome 17 DNA markers in 45 neurofibromatosis 1 families, Genomics 1: 353–357.
Stephens, K., Green, P., Riccardi, V. M., Ng, S., Rising, M., Barker, D., Darby, J. K., Falls, K. M., Collins, F. S., Willard, H. F., and Donis-Keller, H., 1989, Genetic analysis of eight loci tightly linked to neurofibromatosis 1, Am. J. Hum. Genet. 44: 13–19.
Stumpf, D. A., Alksne, J. F., Annegers, J. F., Brown, S. S., Conneally, P. M., Housman, D., Leppert, M. F., Miller, J. P., Moss, M. L., Pileggi, A. J., Rapin, I., Strohman, R. C., Swanson, W., and Zimmerman, A., 1988, Neurofibromatosis, Arch. Neurol. 45: 575–578.
Thomson, A., 1900, On Neuroma and Neurofibromatosis, Trumbull and Spears, Edinburgh.
Trattner, A., David, M., Hodak, E., Ben-David, E., and Sandbank, M., 1990, Segmental neurofibromatosis, J. Am. Acad. Dermatol. 23: 866–869.
Treves, F., 1923, The Elephant Man and Other Reminiscences, Cossell, London.
Upadhyaya, M., Sarfarazi, M., Huson, S. M., and Harper, P. S., 1987a, Further exclusion data for the von Recklinghausen neurofibromatosis gene: A genetic linkage study of 19-polymorphic markers, J. Med. Genet. 24: 534–536.
Upadhyaya, M., Sarfarazi, M., Huson, S. M., Stephens, K., Broadhead, W., and Harper, P. S., 1987b, Chromosome 17 markers and von Recklinghausen neurofibromatosis: A genetic linkage study in a British population, Genomics, 1: 358–360.
Upadhyaya, M., Sarfarazi, M., Huson, S. M., Broadhead, W., Fryer, A., and Harper, P. S., 1989, Close flanking markers for neurofibromatosis type 1 (NF1), Am. J. Hum. Genet. 44: 41–47.
Upadhyaya, M., Cheryson, A., Broadhead, W., Fryer, A., Shaw, D. J., Huson, S., Wallace, M. R., Andersen, L. B., Marchuk, D. A., Viskochil, D., Black, D., O’Connell, P., Collins, F. S., and Harper, P. S., 1990, A 90 kb DNA deletion associated with neurofibromatosis type 1, J. Med. Genet. 27: 738–741.
Van Tuinen, P., Rich, D. C., Summer, K. M., and Ledbetter, D. H., 1987, Regional mapping panel for human chromosome 17: Application to neurofibromatosis type 1, Genomics 1: 371–381.
Vance, J. M., Pericak-Vance, M. A., Yamaoka, L. H., Speer, M. C., Rosenwasser, G. O. D., Small, K., Gaskell, P. C., Jr., Hung, W.-Y., Alberts, M. J., Haynes, C. S., Gilbert, J. R., Aylsworth, A. S., and Roses, A. D., 1989, Genetic linkage mapping of chromosome 17 markers and neurofibromatosis type 1, Am. J. Hum. Genet. 44: 25–29.
Vinores, S. A., 1986, Nerve growth factor modification of the ethylnitrosourea model for multiple Schwannomas, Ann. N. Y. Acad. Sci. 486: 124–131.
Viskochil, D., Buchberg, A. M., Xu, G., Cawthon, R. M., Stevens, J., Wolff, R. K., Culver, M., Carey, J. C., Copeland, N. G., Jenkins, N. A., White, R., and O’Connell, P., 1990, Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus, Cell 62: 187–192.
Viskochil, D., Cawthon, R., O’Connell, P., Xu, G., Stevens, J., Culver, M., Carey, J., and White, R., 1991, The gene encoding the oligodendrocytemyelin glycoprotein is embedded within the neurofibromatosis type 1 gene, Mol. Cell. Biol. 11: 906–912.
Wallace, M. R., Marchuk, D. A., Andersen, L. B., Letcher, R., Odeh, H. M., Saulino, A. M., Fountain, J. W., Brereton, A., Nicholson, J., Mitchell, A. L., Brownstein, B. H., and Collins, F. S., 1990a, Type 1 neurofibromatosis gene: Identification of a large transcript disrupted in three NF1 patients, Science 249: 181–186.
Wallace, M. R., Andersen, L. B., Fountain, J. W., Odeh, H. M., Viskochil, D., Marchuk, D. A., O’Connell, P., White, R., and Collins, F. S., 1990, A chromosome jump crosses a translocation breakpoint in the von Recklinghausen neurofibromatosis region, Genes Chromosomes Cancer 2: 271–277.
Wallace, M. R., Andersen, L. B., Saulino, A. M., Gregory, P., Glover, T., and Collins, F. S., 1991a, A de novo insertion mutation causing neurofibromatosis type 1, submitted.
Wallace, M. R., Martin, A., Marchuk, D. A., Legius, E., Glover, T., Venter, C., and Collins, F. S., 1991, Flanking intron sequence of five additional exons of the human NFJ gene, submitted.
Ward, K., O’Connell, P., Carey, J. C., Leppert, M., Jolley, S., Plaetke, R., Ogden, B., and White, R., 1990, Diagnosis of neurofibromatosis 1 by using tightly linked flanking DNA markers, Am. J. Hum. Genet. 46: 943–949.
Warkany, J., 1981, Friedrich Daniel von Recklinghausen and his times, Adv. Neurol. 29: 251–257.
Watanabe, S., Kiley, K., Martuza, R. L., and Fitzpatrick, T. B., 1989, Melanosomal polymorphism in cultured melanocytes from cafe-au-lait macules in von Recklinghausen neurofibromatosis, J. Invest. Dermatol. 92: 538.
Weber, K., and Braun-Falco, O., 1972, Zur ultrastruktur de neurofibromatose, Havtartz 23: 116–122.
Weichselbaum, R. R., Beckett, M., and Diamond, A., 1988, Some retinoblastoma, osteosarcomas, and soft tissue sarcomas may share a common etiology, Proc. Natl. Acad. Sci. USA 85: 2106–2109.
Wertelecki, V., Rouleau, G. A., Superneau, D. W., Forehand, L. W., Williams, J. P., Haines, J. L., and Gusella, J. F., 1988, Neurofibromatosis 2: Clinical and DNA linkage studies of a large kindred, N. Engl. J. Med. 319: 278–283.
White, R., Nakamura, Y., O’Connell, P., Leppert, M., Lalouel, J.-M., Barker, D., Goldgar, D., Skolnick, M., Carey, J., Wallis, C. E., Slater, C. P., Mathew, C., and Ponder, B., 1987, Tightly linked markers for the neurofibromatosis type 1 gene, Genomics 1: 364–367.
Wigler, M. H., 1990, GAPs in understanding ras, Nature 346: 696–697.
Woods, W. G., McKenzie, B., Letourneau, M. A., and Byrne, T. D., 1986, Sensitivity of cultured skin fibroblasts from patients with neurofibromatosis to DNA-damaging agents, Ann. N. Y. Acad. Sci. 486: 336–348.
Xu, G., O’Connell, P., Viskochil, D., Cawthon, R., Robertson, M., Culver, M., Dunn, D., Stevens, J., Gesteland, R., White, R., and Weiss, R., 1990a, The neurofibromatosis type 1 gene encodes a protein related to GAP, Cell 62: 599–608.
Xu, G., Lin, B., Tanaka, K., Dunn, D., Wood, D., Gesteland, R., White, R., Weiss, R., and Tamanoi, F., 1990b, The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevesiae, Cell 63: 835–841.
Zelkowitz, M., and Stambouly, J., 1981, Short communication: Neurofibromatosis fibroblasts: Slow growth and abnormal morphology, Pediatr. Res. 15: 290–293.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Plenum Press, New York
About this chapter
Cite this chapter
Wallace, M.R., Collins, F.S. (1991). Molecular Genetics of von Recklinghausen Neurofibromatosis. In: Harris, H., Hirschhorn, K. (eds) Advances in Human Genetics. Advances in Human Genetics, vol 20. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5958-6_5
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5958-6_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5960-9
Online ISBN: 978-1-4684-5958-6
eBook Packages: Springer Book Archive